Active ingredient
- levodopa
- carbidopa monohydrate
Legal Category
POM: Prescription only medicine
POM: Prescription only medicine
This short guide provides advice to healthcare professionals on the management of patients with advanced Parkinson’s disease who have started Duodopa therapy
For Healthcare Professionals
The information presented in these slides is provided as part of additional Risk Minimisation Program for Duodopa targeted to minimise: –Gastrointestinal (GI) events –Device-related risks –Procedure-related risks associated with the levodopa – carbidopa intestinal gel (LCIG) system
For Healthcare Professionals
This pocket guide provides a practical overview of the Duodopa system and potential complications related to the medication and its delivery system.
For Healthcare Professionals
This guide provides advice to healthcare professionals on how to minimise PEG-J tube related complications in patients receiving Duodopa therapy. It should be used in conjunction with any local guidance and the CADD-Legacy 1400 pump instruction manual.
For Healthcare Professionals
Important Additional Risk Minimisation Information for Healthcare Professionals Training for AbbVie Duodopa Specialists on LCIG System, PEG-J Placement, Aftercare and Minimisation of Procedure Complications
For Healthcare Professionals
If you would like to make a comment or send us feedback on this material, click here.
AbbVie House, Vanwall Business Park, Vanwall Road, Maidenhead, Berkshire, SL6 4UB, UK
+44 (0)1628 561 092
+44 (0)1628 561 092